Textual content dimension
These studies, excerpted and edited by Barron’s, were issued not long ago by investment and study firms. The reports are a sampling of analysts’ thinking they need to not be deemed the views or tips of Barron’s. Some of the reports’ issuers have offered, or hope to offer, expense-banking or other services to the providers becoming analyzed.
Mid-The united states Condominium Communities
MAA-NYSE
Outperform Selling price $159.38 on May well 10
by Raymond James
We reiterate our Outperform score, with a revised $175 goal cost [up from $145], next our evaluate of 1st-quarter outcomes that continued to demonstrate the resilience and recovery energy of Sunbelt residence rental markets. Propelled by surging occupation relocations and tightening housing inventory, the momentum [is strong] in a lot of of Mid-America’s critical markets, such as Atlanta, Charlotte, Raleigh, and Tampa. Our info also indicate that previously offer-challenged markets, these as Austin and Orlando, are off to phenomenal begins to 2021. We more and more see the employment shifts and populace migration patterns favoring Sunbelt markets as portion of a extended-phrase secular dynamic. With lower prices of dwelling, decreased taxes, and lower density, these marketplaces feel probably to see much better task/money development for years to occur.
CCL Industries
CCL-B.Canada
Outperform Price C$70.90 on Might 12
by BMO Investigate
1st-quarter modified earnings of 82 cents a share ended up earlier mentioned our estimate and the consensus of 75 cents. Altered Ebitda [earnings before interest, taxes, depreciation, and amortization] of $294 million was marginally previously mentioned our estimate of $281 million and the consensus of $283 million. The 2021 outlook stays beneficial for CCL [a label, product-security, and specialty packaging company]. Our price concentrate on is C$78.
Flexion Therapeutics
FLXN-Nasdaq
Acquire Price tag $7.53 on May 12
by Needham
Flexion experienced preannounced first-quarter revenue of Zilretta [a time-release osteoarthritis knee-pain treatment, sales of which totalled $24.6 million, 22% above the year-earlier level.] So, its quarterly update largely targeted on pipeline assets and a chief money officer change.
Original success from the section 1 demo of Forex201 [an osteoarthritis drug using gene therapy] were just lately presented they confirmed initial indicators of efficacy and security. Final results from expanded mid- and high-dose Forex201 cohorts are expected by the end of 2021. Zilretta will remain FLXN’s key price driver for the foreseeable long run, but we believe that that Forex201 and Forex301 [a therapy for curbing postsurgical pain] have the potential to develop additional shareholder price. We maintain our $20 selling price target.
BorgWarner
BWA-NYSE
Neutral Price tag $51.12 on Might 6
by Guggenheim
BorgWarner sent considerably superior than expected to start with-quarter benefits, and increased its fiscal 2021 steerage. Revenue was about 13% forward of the consensus estimate, and the initially joint get was announced for BWA’s iDM product or service [an axle that incorporates transmission, electric motor, and power electronics for hybrid and electric vehicles] because closing the Delphi acquisition. This products is significant for enhancing BorgWarner’s battery/electric powered car or truck narrative. Fiscal 2021 margin guidance appears conservative, despite the fact that there are threats close to in the vicinity of-time period production disruptions. BWA carries on to execute incredibly perfectly, and its valuation is not overly demanding. But its aggressive [product] portfolio repositioning and ongoing require to reveal battery/electrical car positioning are likely to obstacle several expansion, in close proximity to-term.
Marathon Oil
MRO-NYSE
Overweight Price $11.54 on May possibly 12
by
Wells Fargo
We had the option to host investor calls with MRO Chairman and CEO Lee Tillman and VP of Trader Relations Dude Baber. Even though a whole lot of floor was protected, the important theme was the tension among Marathon Oil’s strong absolutely free funds-stream opportunity and disciplined system in excess of the subsequent five yrs, and investors’ searching for clarity on the longevity of MRO’s inventory and what (if any) part the organization may well enjoy in consolidation heading ahead.
Our essential takeaway: A relentless focus on charge regulate has positioned MRO to return substance hard cash to shareholders, but management wants to retain optionality on how to do so. Even though the near-phrase concentration is on personal debt reduction, all avenues of dollars return—variable dividends, distinctive dividends, share buybacks and so on.—are open up further than 2021. We elevate our rate target to $17, from $15.
NV5 World
NVEE-Nasdaq
Keep Selling price $81.30 on Might 12
by Maxim Team
We enhance our forecasts for NV5 just after it documented to start with-quarter earnings and Ebitda below consensus, but released comprehensive-12 months 2021 revenue and EPS steering higher than expectations. Negative temperature in the quarter delayed some tasks planned by NV5 [an infrastructure consultancy], primary to revenue of $153.1 million, down below our $159.7 million forecast and the $161.3 million consensus estimate. We keep our Maintain ranking, based mostly on the potential for purchase and job delays from inefficient acceptance processes as government companies change priorities amid Covid-19.
E mail: editors@barrons.com
